Teva Pharmaceutical Industries Ltd (TEVJF) Convertible Debt (2009 - 2010)
Teva Pharmaceutical Industries' (TEVJF) quarterly Convertible Debt came in at $13.0 million in Q4 2010, down 98.41% YoY from $817.0 million in Q4 2009, and down 7.14% on a QoQ basis from $14.0 million in Q3 2010.
Teva Pharmaceutical Industries Ltd (TEVJF) Convertible Debt (2009 - 2010) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 2 years of Convertible Debt data on file, last reported at $13.0 million in Q4 2010.
- Quarterly Convertible Debt fell 98.41% year-over-year to $13.0 million in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $13.0 million (down 98.41% YoY) and the FY2010 annual result came in at $13.0 million, down 98.41% from the prior year.
- Convertible Debt declined to $13.0 million in Q4 2010, from $14.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $1.2 billion in Q1 2009 to a low of $13.0 million in Q4 2010.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 13.00 Mn |
| Sep 30, 2010 | 14.00 Mn |
| Jun 30, 2010 | 21.00 Mn |
| Mar 31, 2010 | 47.00 Mn |
| Dec 31, 2009 | 817.00 Mn |
| Sep 30, 2009 | 832.00 Mn |
| Jun 30, 2009 | 861.00 Mn |
| Mar 31, 2009 | 1.21 Bn |